Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tatva Chintan Pharma Chem has informed that it enclosed schedule of Analyst / Institutional Investor Meeting to be held on 8 March 2022, as under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.